Nasdaq-listed Predictive Oncology launches $344M DePIN treasury focused on Aethir
Predictive Oncology (POAI), a biotech firm known for AI-driven cancer research, has initiated a $344.4 million digital asset treasury focused on Aethir’s ATH token. This venture marks the first instance of a Nasdaq-listed company holding and managing tokens from a Decentralized Physical Infrastructure Network (DePIN). The funding strategy